『This Moment in Medicine: T-DXd in Early HER2+ BC with Dr. Michelina Cairo』のカバーアート

This Moment in Medicine: T-DXd in Early HER2+ BC with Dr. Michelina Cairo

This Moment in Medicine: T-DXd in Early HER2+ BC with Dr. Michelina Cairo

無料で聴く

ポッドキャストの詳細を見る

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり

Where should T-DXd fit in the treatment of high-risk, early-stage HER2-positive breast cancer?


At This Moment in Medicine, hosted by Community Health Media, Dr. Michelina Cairo reviews the latest data from DESTINY-Breast11 and DESTINY-Breast05, examining how trastuzumab deruxtecan (T-DXd) could reshape treatment in both the neoadjuvant and adjuvant settings.


From pathologic complete response and invasive disease-free survival to ILD risk and treatment sequencing, the presentation explores how clinicians might balance efficacy, toxicity, and individual recurrence risk as T-DXd moves into earlier-stage disease.


Topics discussed:

  • Current treatment for high-risk HER2-positive early breast cancer
  • DESTINY-Breast11 and neoadjuvant T-DXd followed by THP
  • Pathologic complete response and residual cancer burden
  • DESTINY-Breast05 and T-DXd versus T-DM1
  • Invasive disease-free survival and emerging CNS outcomes
  • ILD, nausea, cardiac safety, and treatment duration
  • Neoadjuvant versus adjuvant use of T-DXd
  • Whether THP alone may be sufficient for selected patients
  • The potential role of ctDNA
  • Where T-DM1 may still fit for residual disease
  • Individualizing treatment according to recurrence risk


The presentation concludes with a panel discussion exploring one of the biggest unanswered questions: How much T-DXd is enough—and when should it be used?


▶️ Watch more from This Moment in Medicine and subscribe to Community Health Media for expert conversations on the latest advances shaping cancer care.

🎧 Subscribe for the latest insights from leading cancer specialists.


#ThisMomentInMedicine #MichelinaCairo #BreastCancer #HER2Positive #TDXd #TrastuzumabDeruxtecan #DESTINYBreast11 #DESTINYBreast05 #BreastOncology #MedicalOncology #CommunityHealthMedia

–


Thanks for watching!


Our podcasts are also available on:

• Spotify - https://spotf.fi/chm-podcast

• Amazon Music - https://amazn.so/chm-podcast

• Apple Podcast - https://podcasts.apple.com/us/podcast/community-health-media/id1837428248

• Castbox - https://castbox.fm/vh/6735434

• Goodpods - https://goodpods.com/profile/chm-111066

• iHeartRadio - https://iheart.com/podcast/291542082

• Pocket Casts - https://pca.st/3ncdh11o


–


Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.


We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.


We specialize in:

• Peer to peer interviews, panels & round-tables

• Curated live events & conferences

• Professional in-depth content & research updates

• Interactive learning modules & webinars

• Live & on-demand webcasts & podcasts


Learn more about us here - https://communityhealth.media

adbl_web_anon_alc_button_suppression_t1
まだレビューはありません